IBDEI3GI ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,58146,1,4,0)
;;=4^H40.63X3
;;^UTILITY(U,$J,358.3,58146,2)
;;=^5005917
;;^UTILITY(U,$J,358.3,58147,0)
;;=H40.63X4^^272^2901^29
;;^UTILITY(U,$J,358.3,58147,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58147,1,3,0)
;;=3^Drug-Induced Glaucoma,Bilateral,Indeterminate Stage
;;^UTILITY(U,$J,358.3,58147,1,4,0)
;;=4^H40.63X4
;;^UTILITY(U,$J,358.3,58147,2)
;;=^5005918
;;^UTILITY(U,$J,358.3,58148,0)
;;=H40.51X0^^272^2901^54
;;^UTILITY(U,$J,358.3,58148,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58148,1,3,0)
;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Unspec Stage
;;^UTILITY(U,$J,358.3,58148,1,4,0)
;;=4^H40.51X0
;;^UTILITY(U,$J,358.3,58148,2)
;;=^5005888
;;^UTILITY(U,$J,358.3,58149,0)
;;=H40.51X1^^272^2901^55
;;^UTILITY(U,$J,358.3,58149,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58149,1,3,0)
;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Mild Stage
;;^UTILITY(U,$J,358.3,58149,1,4,0)
;;=4^H40.51X1
;;^UTILITY(U,$J,358.3,58149,2)
;;=^5005889
;;^UTILITY(U,$J,358.3,58150,0)
;;=H40.51X2^^272^2901^56
;;^UTILITY(U,$J,358.3,58150,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58150,1,3,0)
;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Moderate Stage
;;^UTILITY(U,$J,358.3,58150,1,4,0)
;;=4^H40.51X2
;;^UTILITY(U,$J,358.3,58150,2)
;;=^5005890
;;^UTILITY(U,$J,358.3,58151,0)
;;=H40.51X3^^272^2901^57
;;^UTILITY(U,$J,358.3,58151,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58151,1,3,0)
;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Severe Stage
;;^UTILITY(U,$J,358.3,58151,1,4,0)
;;=4^H40.51X3
;;^UTILITY(U,$J,358.3,58151,2)
;;=^5133507
;;^UTILITY(U,$J,358.3,58152,0)
;;=H40.51X4^^272^2901^58
;;^UTILITY(U,$J,358.3,58152,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58152,1,3,0)
;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Indeterminate Stage
;;^UTILITY(U,$J,358.3,58152,1,4,0)
;;=4^H40.51X4
;;^UTILITY(U,$J,358.3,58152,2)
;;=^5005891
;;^UTILITY(U,$J,358.3,58153,0)
;;=H40.52X0^^272^2901^49
;;^UTILITY(U,$J,358.3,58153,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58153,1,3,0)
;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Unspec Stage
;;^UTILITY(U,$J,358.3,58153,1,4,0)
;;=4^H40.52X0
;;^UTILITY(U,$J,358.3,58153,2)
;;=^5005892
;;^UTILITY(U,$J,358.3,58154,0)
;;=H40.52X1^^272^2901^50
;;^UTILITY(U,$J,358.3,58154,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58154,1,3,0)
;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Mild Stage
;;^UTILITY(U,$J,358.3,58154,1,4,0)
;;=4^H40.52X1
;;^UTILITY(U,$J,358.3,58154,2)
;;=^5005893
;;^UTILITY(U,$J,358.3,58155,0)
;;=H40.52X2^^272^2901^51
;;^UTILITY(U,$J,358.3,58155,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58155,1,3,0)
;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Moderate Stage
;;^UTILITY(U,$J,358.3,58155,1,4,0)
;;=4^H40.52X2
;;^UTILITY(U,$J,358.3,58155,2)
;;=^5005894
;;^UTILITY(U,$J,358.3,58156,0)
;;=H40.52X3^^272^2901^52
;;^UTILITY(U,$J,358.3,58156,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58156,1,3,0)
;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Severe Stage
;;^UTILITY(U,$J,358.3,58156,1,4,0)
;;=4^H40.52X3
;;^UTILITY(U,$J,358.3,58156,2)
;;=^5133508
;;^UTILITY(U,$J,358.3,58157,0)
;;=H40.52X4^^272^2901^53
;;^UTILITY(U,$J,358.3,58157,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58157,1,3,0)
;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Indeterminate Stage
;;^UTILITY(U,$J,358.3,58157,1,4,0)
;;=4^H40.52X4
;;^UTILITY(U,$J,358.3,58157,2)
;;=^5005895
;;^UTILITY(U,$J,358.3,58158,0)
;;=H40.53X0^^272^2901^44
;;^UTILITY(U,$J,358.3,58158,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3GI 3928 printed Nov 22, 2024@17:58:28 Page 2
IBDEI3GI ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,58146,1,4,0)
+2 ;;=4^H40.63X3
+3 ;;^UTILITY(U,$J,358.3,58146,2)
+4 ;;=^5005917
+5 ;;^UTILITY(U,$J,358.3,58147,0)
+6 ;;=H40.63X4^^272^2901^29
+7 ;;^UTILITY(U,$J,358.3,58147,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,58147,1,3,0)
+10 ;;=3^Drug-Induced Glaucoma,Bilateral,Indeterminate Stage
+11 ;;^UTILITY(U,$J,358.3,58147,1,4,0)
+12 ;;=4^H40.63X4
+13 ;;^UTILITY(U,$J,358.3,58147,2)
+14 ;;=^5005918
+15 ;;^UTILITY(U,$J,358.3,58148,0)
+16 ;;=H40.51X0^^272^2901^54
+17 ;;^UTILITY(U,$J,358.3,58148,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,58148,1,3,0)
+20 ;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Unspec Stage
+21 ;;^UTILITY(U,$J,358.3,58148,1,4,0)
+22 ;;=4^H40.51X0
+23 ;;^UTILITY(U,$J,358.3,58148,2)
+24 ;;=^5005888
+25 ;;^UTILITY(U,$J,358.3,58149,0)
+26 ;;=H40.51X1^^272^2901^55
+27 ;;^UTILITY(U,$J,358.3,58149,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,58149,1,3,0)
+30 ;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Mild Stage
+31 ;;^UTILITY(U,$J,358.3,58149,1,4,0)
+32 ;;=4^H40.51X1
+33 ;;^UTILITY(U,$J,358.3,58149,2)
+34 ;;=^5005889
+35 ;;^UTILITY(U,$J,358.3,58150,0)
+36 ;;=H40.51X2^^272^2901^56
+37 ;;^UTILITY(U,$J,358.3,58150,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,58150,1,3,0)
+40 ;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Moderate Stage
+41 ;;^UTILITY(U,$J,358.3,58150,1,4,0)
+42 ;;=4^H40.51X2
+43 ;;^UTILITY(U,$J,358.3,58150,2)
+44 ;;=^5005890
+45 ;;^UTILITY(U,$J,358.3,58151,0)
+46 ;;=H40.51X3^^272^2901^57
+47 ;;^UTILITY(U,$J,358.3,58151,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,58151,1,3,0)
+50 ;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Severe Stage
+51 ;;^UTILITY(U,$J,358.3,58151,1,4,0)
+52 ;;=4^H40.51X3
+53 ;;^UTILITY(U,$J,358.3,58151,2)
+54 ;;=^5133507
+55 ;;^UTILITY(U,$J,358.3,58152,0)
+56 ;;=H40.51X4^^272^2901^58
+57 ;;^UTILITY(U,$J,358.3,58152,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,58152,1,3,0)
+60 ;;=3^Glaucoma Sec to Oth Eye Disorder,Right Eye,Indeterminate Stage
+61 ;;^UTILITY(U,$J,358.3,58152,1,4,0)
+62 ;;=4^H40.51X4
+63 ;;^UTILITY(U,$J,358.3,58152,2)
+64 ;;=^5005891
+65 ;;^UTILITY(U,$J,358.3,58153,0)
+66 ;;=H40.52X0^^272^2901^49
+67 ;;^UTILITY(U,$J,358.3,58153,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,58153,1,3,0)
+70 ;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Unspec Stage
+71 ;;^UTILITY(U,$J,358.3,58153,1,4,0)
+72 ;;=4^H40.52X0
+73 ;;^UTILITY(U,$J,358.3,58153,2)
+74 ;;=^5005892
+75 ;;^UTILITY(U,$J,358.3,58154,0)
+76 ;;=H40.52X1^^272^2901^50
+77 ;;^UTILITY(U,$J,358.3,58154,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,58154,1,3,0)
+80 ;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Mild Stage
+81 ;;^UTILITY(U,$J,358.3,58154,1,4,0)
+82 ;;=4^H40.52X1
+83 ;;^UTILITY(U,$J,358.3,58154,2)
+84 ;;=^5005893
+85 ;;^UTILITY(U,$J,358.3,58155,0)
+86 ;;=H40.52X2^^272^2901^51
+87 ;;^UTILITY(U,$J,358.3,58155,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,58155,1,3,0)
+90 ;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Moderate Stage
+91 ;;^UTILITY(U,$J,358.3,58155,1,4,0)
+92 ;;=4^H40.52X2
+93 ;;^UTILITY(U,$J,358.3,58155,2)
+94 ;;=^5005894
+95 ;;^UTILITY(U,$J,358.3,58156,0)
+96 ;;=H40.52X3^^272^2901^52
+97 ;;^UTILITY(U,$J,358.3,58156,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,58156,1,3,0)
+100 ;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Severe Stage
+101 ;;^UTILITY(U,$J,358.3,58156,1,4,0)
+102 ;;=4^H40.52X3
+103 ;;^UTILITY(U,$J,358.3,58156,2)
+104 ;;=^5133508
+105 ;;^UTILITY(U,$J,358.3,58157,0)
+106 ;;=H40.52X4^^272^2901^53
+107 ;;^UTILITY(U,$J,358.3,58157,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,58157,1,3,0)
+110 ;;=3^Glaucoma Sec to Oth Eye Disorder,Left Eye,Indeterminate Stage
+111 ;;^UTILITY(U,$J,358.3,58157,1,4,0)
+112 ;;=4^H40.52X4
+113 ;;^UTILITY(U,$J,358.3,58157,2)
+114 ;;=^5005895
+115 ;;^UTILITY(U,$J,358.3,58158,0)
+116 ;;=H40.53X0^^272^2901^44
+117 ;;^UTILITY(U,$J,358.3,58158,1,0)
+118 ;;=^358.31IA^4^2
